Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease

Clinical trial NCT03398577 · UNKNOWN

Trial details

NCT number: NCT03398577
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Disease With Diabetes Mellitus

Start date: 2018-02-01
Primary completion: 2018-08-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.